West Coast Molecular Science Group is guided by physician leadership dedicated to advancing molecular diagnostics and precision oncology. Our leadership team brings clinical experience, scientific insight, and a shared commitment to helping healthcare professionals translate emerging evidence into practical, patient-centered oncology care.
Our Leadership Foundation
Leadership Driven by Clinical Experience
The leadership of West Coast Molecular Science Group draws upon extensive experience in oncology and the real-world application of molecular diagnostics. Our educational programs are developed around authentic clinical cases, current scientific evidence, and emerging advances in precision medicine. WCMSG ensures every discussion remains practical, balanced, and focused on helping healthcare professionals interpret complex molecular data and integrate it thoughtfully into oncology practice.
Learn From Physician Leaders in Oncology
Strong physician leadership is the foundation of every West Coast Molecular Science Group program. Learn about our upcoming meetings, collaborate with our growing community, or reach out to discover how you can participate in advancing precision oncology through education and scientific exchange.
Afshin Eli Gabayan, M.D.
President & Medical Director, West Coast Molecular Science Group
Board-Certified in Hematology & Oncology
Leading Oncologist and Clinical Researcher in Los Angeles
Dr. Afshin Eli Gabayan, known professionally as A. Eli Gabayan, M.D., is a highly regarded hematologist and medical oncologist whose career has been guided by a steadfast focus on evidence-based, outcomes-driven cancer care. As President & Medical Director of West Coast Molecular Science Group, Dr. Gabayan is pivotal in driving the organization’s mission to advance molecular diagnostics and precision oncology, helping physicians identify optimal, personalized treatment strategies for patients with difficult-to-treat cancers.
Read More
Dr. Gabayan founded West Coast Molecular Science Group to share real patient stories and clinical insights on the use of molecular diagnostics in guiding cancer therapy selection. Through ongoing case reviews with fellow physicians and molecular pathology experts, he helps translate complex diagnostic findings into practical, evidence-based treatment decisions—furthering the goal of precision medicine that improves outcomes and quality of life for patients facing the most challenging tumor types.
Sharon Neman
Executive Director, West Coast Molecular Science Group
Sharon Neman is a healthcare executive dedicated to advancing physician education and expanding access to precision medicine in oncology. As Executive Director of Educational Programming at West Coast Molecular Science Group, Sharon leads the organization’s efforts to translate molecular diagnostics and tumor board insights into meaningful educational programs for hematology-oncology physicians across teaching institutions and community practices alike.
Read More
Sharon brings a strategic, multidisciplinary perspective shaped by her prior work in consulting at Deloitte & Touche and in commercial real estate at Douglas Emmett, Inc. She holds both a B.S. and an M.B.A. from the USC Marshall School of Business, where she received the Emma Josephine Bradley Bovard Award for top academic achievement and extracurricular service. Today, Sharon is focused on expanding West Coast Molecular Science Group’s educational reach, helping bring the insights of precision oncology to more physicians and, ultimately, their patients.
Mariana Nelson
Director of Business Development & Industry Relations
Mariana Nelson serves as the Director of Business Development & Industry Relations at West Coast Molecular Science Group. She leads partnerships with pharmaceutical, biotechnology, and molecular diagnostics companies to support WCMSG’s independent educational programs in oncology and hematology. Mariana oversees sponsor and exhibitor relationships while driving marketing initiatives that connect healthcare professionals with evidence-based educational events. She works closely with industry partners and internal leadership to expand WCMSG’s reach and advance precision oncology education. Her focus is on building meaningful collaborations that support high-quality education and improve patient care.
